Sanity Group Funding Round

9/27/2022

Venture Equity

$37,600,000

Series B

The company intends to use the funds to accelerate its growth, enable European expansion and strengthen research and development activities.

Private & Independent

Biopharmaceutical

Jägerstraße 28-31
Berlin, 10117
DE

Undisclosed

At Sanity Group, we have a clear goal: Unlocking the health benefits of cannabinoids. To achieve this ambitious goal, we live a corporate culture that balances high performance with continuous personal development. Our values guide both our behavior and our decision-making. They define the standard of quality for all the products we develop, how we talk to customers, who we hire and how we work with our colleagues. Our "People First!" culture allows us to build on a transparent environment with a strong sense of ownership and continuous improvement. If you want to learn more and become part of the European cannabis revolution, we invite you to take a look at our careers page!